AVITA Medical (RCEL) Long-Term Investments (2021 - 2023)

AVITA Medical's Long-Term Investments history runs 3 years deep, the most recent figure standing at $2.8 million for Q2 2023.

• Quarterly Long-Term Investments fell 59.16% year-over-year to $2.8 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $2.8 million (down 59.16% YoY) and the FY2022 annual result came in at $6.9 million, down 64.81% from the prior year.
• Long-Term Investments was $2.8 million for Q2 2023 at AVITA Medical, down from $4.2 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $19.8 million in Q3 2021 and bottomed at $2.8 million in Q2 2023.
• A 3-year average of $9.5 million and a median of $6.8 million in 2022 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2022 — Long-Term Investments tumbled 79.74% — and 2023, when it slumped 59.16%.
• AVITA Medical's Long-Term Investments stood at $19.7 million in 2021, then sank by 64.81% to $6.9 million in 2022, then tumbled by 60.26% to $2.8 million in 2023.
• Business Quant data shows RCEL's Long-Term Investments at $2.8 million in Q2 2023, $4.2 million in Q1 2023, and $6.9 million in Q4 2022.